ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Monday reported profit of $38.5 million in its third quarter.

The Rockville, Maryland-based company said it had net income of 69 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.06 per share.

The drugmaker posted revenue of $175.7 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $155.1 million.

Supernus expects full-year revenue in the range of $630 million to $650 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN